MIRA INFORM REPORT

 

 

Report Date :

24.06.2011

 

IDENTIFICATION DETAILS

 

Name :

INTERQUIM SA

 

 

Registered Office :

Calle Joan Buscalla, 10, 08173 Sant Cugat Del Valles  Barcelona

 

 

Country :

Spain

 

 

Financials (as on) :

31.12.2009

 

 

Date of Incorporation :

13.11.1978

 

 

Legal Form :

Joint Stock Company

 

 

Line of Business :

Manufacturer of basic pharmaceutical products

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

787.000,00 €

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

No Complaints

 

 

Litigation :

Clear

 


NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31st, 2011

 

Country Name

Previous Rating

                   (31.12.2010)                  

Current Rating

(31.03.2011)

Spain

a2

a2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


Company name  

 

INTERQUIM SA

TAX NUMBER: A08536476

 

EXECUTIVE SUMMARY

 

Identification

Current Business Name: INTERQUIM SA

Other names:  YES

Current Address:  CALLE JOAN BUSCALLA, 10

08173 SANT CUGAT DEL VALLES BARCELONA 

Telephone number: 935044200 Fax: 936742954

URL:  www.ferrergrupo.com  

Corporate e-mail:  interquim@ferrergrupo.com   

 

Trade Risk

 

Credit Appraisal: 787.000,00 €

Incidents:  NO

Bank and business defaults of payment - ASNEF INDUSTRIAL:  NO

 

Financial Information

 

Balance sheet latest sales (2009): 35.933.510,00 € (Trade Register)

Result: 2.163.425 €

Total Assets: 48.620.748 €

Social Capital:  833.202,00 €

Employees:  92

Listed on a Stock Exchange: NO

  


Commercial Information

 

Incorporation date:  13/11/1978

Activity:  Mfg. of basic pharmaceutical products

NACE 2009 CODE: 2110

International Operations:  Imports and Exports

 

Corporate Structure

 

President: 

 FERRER SALAT SERRA DI MIGNI SERGIO

Parent Company: 

 GRUPO FERRER INTERNACIONAL SA

Participations:  1

 

Other Complementary Information

 

Latest act published in BORME:  22/11/2010 Company’s mergers and takeovers

Latest press article:  18/11/2010 CINCO DIAS (LEGAL ANNOUNCEMENTS)

Bank Entities:  There are

 

The date when this report was last updated is 21/12/2010.

The information contained in this report has been investigated and contrasted on 01/02/2010

 

   

Credit Appraisal

 

Maximum Credit

(from 0 to 6,000,000 €)

Favourable to 787.000,00 €


Rating Evolution

 

  

Financial Situation

Exercise:2009

Treasury

Very good

Indebtedness

Bad

Profitability

Sufficient

Balance

Very good

 

Performance

 

Incidents

None or Negligible

Business Trajectory

Excellent

 

 


INCIDENTS

 

Summary

LEGAL ACTIONS: No legal actions registered

ADMINISTRATIVE CLAIMS: No administrative claims registered

AFFECTED BY: No significant element.

 

BANK AND BUSINESS DEFAULTS OF PAYMENT - ASNEF INDUSTRIAL

 

FINANCIAL ELEMENTS AND SECTORIAL COMPARATIVE

 

FINANCIAL ELEMENTS

The shaded amounts in the following financial statements have been converted to the norms established in the PGC2007 derived from RD 1514/2007 and 1515/2007, this way comparatives could be shown with the amounts of exercises initiated from 1/01/08.

 

Balance-sheet analysis

Figures given in €

 

31/12/2009

(12)

 

%

ASSETS

 

31/12/2008

(12)

 

%

ASSETS

 

31/12/2007

(12)

 

%

ASSETS

 

ASSETS

 

 

 

 

 

 

A) NON CURRENT ASSETS

20.527.268,00

42,22

18.500.615,00

44,58

16.641.228,00

43,25

B) CURRENT ASSETS

28.093.480,00

57,78

22.998.596,00

55,42

21.834.967,00

56,75

LIABILITIES

 

 

 

 

 

 

A) NET WORTH

25.201.514,00

51,83

24.038.089,00

57,92

25.689.893,00

66,77

B) NON CURRENT LIABILITIES

1.190.555,00

2,45

1.491.475,00

3,59

3.859.077,00

10,03

C) CURRENT LIABILITIES

22.228.679,00

45,72

15.969.647,00

38,48

8.927.225,00

23,20

 

 

 

  A) NON CURRENT ASSETS

  B) CURRENT ASSETS

 

  A) NET WORTH

  B) NON CURRENT LIABILITIES

  C) CURRENT LIABILITIES

 

 

  

Balance Sheet Comments

Total assets of the company  grew in 17,16%  between 2.008 and 2.009.

This growth has been inferior in the case of the non current assets that increased just in  10,95%.

This growth has been mainly financed with a debt increase of 34,12%. Nevertheless Net Worth grew 4,84%.

Total assets of the company  grew in 7,86%  between 2.007 and 2.008.

This growth is a consequence of non current assets increase in 11,17%.

This growth has been financed with an indebtedness increase of 36,56. Besides, Net Worth has reduced in 6,43%, which explains a part of the indebtedness increase.

 


Profit and Loss Account Analysis

Figures given in €

 

31/12/2009

(12)

 

% NET TURNOVER

31/12/2008

(12)

 

% NET TURNOVER

31/12/2007

(12)

 

% NET TURNOVER

SALES

35.933.510,00

 

43.113.261,00

 

39.342.473,00

 

GROSS MARGIN

25.674.688,00

71,45

26.879.790,00

62,35

22.949.104,00

58,33

EBITDA

5.072.606,00

14,12

8.202.191,00

19,02

4.916.813,00

12,50

EBIT

2.821.173,00

7,85

6.377.842,00

14,79

2.507.838,00

6,37

NET RESULT

2.163.425,00

6,02

3.854.836,00

8,94

2.005.555,00

5,10

EFFECTIVE TAX RATE (%)

1,26

0,00

37,22

0,00

15,74

0,00

 

 

Profit and Loss Account Comments

The company’s sales figure  decreased in 16,65% between 2.008 and 2.009.

The company’s EBIT  decreased in 55,77% between 2.008 and 2.009.

This evolution implies a reduction in the economic profitability of the company .

The result of these variations is a decrease of the company’s Operating Profitability of 52,84% in the analysed period, being this profitability of 11,04% in the year 2.009.

The Net Result of the company  decreased in 43,88% between 2.008 and 2.009.

The company’s Financial Profitability has been negatively affected by the financial activities in comparison with EBITs behaviour .

The result of these variations is a reduction of the company’s economic profitability of 65,97% in the analysed period, being equal to 8,69% in the year 2.009 .

The company’s sales figure  grew in 9,58% between 2.007 and 2.008.

The company’s EBIT  grew in 154,32% between 2.007 and 2.008.

This evolution implies an increase in the company’s economic profitability .

The result of these variations is an increase of the company’s Economic Profitability of 83,18% in the analysed period, being equal to 23,41% in the year 2.008.

The Net Result of the company  grew in 92,21% between 2.007 and 2.008.

The company’s Financial Profitability has been positively affected by the financial activities in comparison with EBITs behaviour .

The result of these variations is an increase of the company’s Economic Profitability of 175,51% in the analysed period, being equal to 25,54% in the year 2.008 .

 

 

COMPARATIVE SECTOR ANALYSIS 

 

Values table

Figures expressed in %

 

COMPANY

(2009)

 

SECTOR

DIFFERENCE

BALANCE SHEET ANALYSIS: % on the total assets

 

 

 

ASSETS

A) NON CURRENT ASSETS

42,22

46,64

-4,42

A) CURRENT ASSETS

57,78

53,36

4,42

LIABILITIES

A) NET WORTH

51,83

49,80

2,03

B) NON CURRENT LIABILITIES

2,45

15,67

-13,22

C) CURRENT LIABILITIES

45,72

34,53

11,19

 

 

 

 

 

COMPANY

(2009)

 

SECTOR

DIFFERENCE

PROFIT AND LOSS ACCOUNT ANALYSIS: % on the total operating income

 

 

 

SALES

99,78

94,05

5,73

GROSS MARGIN

71,29

59,68

11,61

EBITDA

14,09

16,02

-1,93

EBIT

7,83

8,82

-0,98

NET RESULT

6,01

5,27

0,73

 

Sector Composition

Compared sector (NACE 2009): 211

Number of companies: 20

Size (Sales Figure): 7,000,000.00 - 40,000,000.00 Euros

 

Comments on the sectorial comparative

Compared to its sector the assets of the companies show  an inferior proportion of non current assets. Specifically the difference with the sector average is -4,42% .

In liabilities composition the company appeals on a wider scale to self financing, being the proportion of Net Worth of 2,03% major. As a consequence, external financing sources are less used by the company ( 2,03% less than the sector) .

The proportion that the sales mean to the company’s total ordinary income is 99,78% , an 5,73% higher than in the sector .

The company’s EBIT was positive and was 7,83% with regard to the total ordinary income, 0,98% inferior to the one of the sector .

The company’s capacity to generate operating income is inferior to that of the sector as its ratio EBIT/Sales is inferior (0,08 in comparison with 0,09) .

The company’s net result was positive and equal to 6,01% with regard to the total ordinary income, 0,73% superior to the one of the sector .

The financial results and the tax impact have had a less negative impact on the net result of the company that in the sector .

 

OTHER DATA FROM THE ANNUAL FINANCIAL REPORT

 

Results Distribution

Source: annual financial report 2009

Figures given in €

DISTRIBUTION BASE

APPLICATION A

Profit and Loss

2.163.425,00

Legal Reserve

0,00

Carry Over

0,00

Voluntary Reserve

2.163.425,00

Voluntary reserves

0,00

Prior years losses

0,00

Reserves

0,00

Carry Over

0,00

Other concepts

0,00

Other funds

0,00

Total of Amounts to be distributed

2.163.425,00

Dividends

0,00

 

 

Other Applications

0,00

 

Auditing

Source: filing of annual financial statement 2009

Auditors’ opinion: FAVOURABLE WITH RESERVATIONS

Auditor: DELOITTE S.L.

 

Auditing exceptions: 

LA MEMORIA DE LAS CUENTAS ANUALES ADJUNTAS NO REFLEJA LA INFORMACION REQUERIDA POR LA NORMATIVA EN VIGOR EN RELACION CON LAS RETRIBUCIONES Y OTRAS PRESTACIONES A LA ALTA DIRECCION NI LA CORRESPONDIENTE A LOS ADMINISTRADORES DE LA SOCIEDAD POR LAS RAZONES INDICADAS EN LA NOTA 18.3 DE LA MEMORIA ADJUNTA.

 

Facts subsequent to the closing

Source: Annual financial report 2009

Con posterioridad al cierre no se han producido hechos de relevancia que requieran su inclusión en las cuentas anuales.

 

(After the close there were no significant events that require their inclusion in the annual accounts.)

 

 

ADDRESSES

  

Business address

Current Legal Seat Address: 

CALLE JOAN BUSCALLA, 10

08173 SANT CUGAT DEL VALLES  BARCELONA

 

 

CORPORATE STRUCTURE

 

ADMINISTRATIVE LINKS

  

Main Board members, Directors and Auditor

POSITION

NAME AND SURNAME

APPOINTMENT DATE

PRESIDENT

FERRER SALAT SERRA DI MIGNI SERGIO

10/09/2008

MEMBER OF THE BOARD

GRUPO FERRER INTERNACIONAL SA

10/09/2008

MEMBER OF THE BOARD

RAMENTOL MASSANA JORGE

30/10/2009

  AUDITOR

APPOINTMENT DATE

DELOITTE SL

17/09/2010

There are 4 board members, directors and auditors registered

Functional Managers

POSITION

NAME AND SURNAME

General Manager

RAMENTOL MASSANA JORGE

Financial Director

FANES TRILLO JUAN

Commercial Director

MUNTANE LLIBERT

 


FINANCIAL LINKS

Shareholders

 

BUSINESS NAME

CIF / COUNTRY

%

SOURCE

DATE REP.

 

GRUPO FERRER INTERNACIONAL SA

A61738993

99,99

OWN SOURCES

01/02/2010

There are 1 direct financial links through shareholders registered

 

Participations

 

 

BUSINESS NAME

CIF / COUNTRY

%

SOURCE

DATE REP.

 

INVERSIONES GFISA 1199 SICAV SA.

A62169545

19,06

TRADE REG.

31/12/2009

There are 1 direct financial links through participations registered

 

CREDIT INFORMATION

   

Constitution

Incorporation date: 13/11/1978

 

Activity

Activity: Mfg. of basic pharmaceutical products

NACE 2009 CODE: 2110

NACE 2009 Activity: Manufacture of basic pharmaceutical products

Business: Fabricación, transformación y distribución de especialidades farmacéuticas. Explotación de los bienes muebles e inmuebles que integran el patrimonio de la sociedad. Gestión y asesoramiento de empresas, prestación de servicios informáticos contables, laborales, administrativos y de estrategia comercial e industrial. Participación en otras sociedades y tenencia e inversión en activos financieros, obligaciones, acciones y participaciones en otras sociedades. Compraventa, administración y negociación de toda clase de valores.

(Production, processing and distribution of pharmaceutical products. Immovable and movable property comprising the assets of the company. Management and advisory companies, providing computerized accounting services, labor, administrative and commercial and industrial strategy. Shares in other companies and holding and investing in financial assets, bonds, stocks and shares in other companies. Sales, administration and negotiation of all kinds of securities.)

 

Activity description: FABRICACION DE PRINCIPIOS ACTIVOS FARMACEUTICOS

 

(Manufacture of active pharmaceutical)

Environmental information: YES (Page 64 - 65)  Annual financial report 2009

 

Employees

Latest employees figure: 92 (2010)

% of fixed employees: 96,74%

% of temporary employees: 3,26%

% of men: 42,39%

% of women: 57,61%

 

Employees evolution

 

 

 

 

Employees distribution

Source: Annual financial report 2009

CATEGORY

TOTAL PER CATEGORY

MEN

WOMEN

Distribución por sexo

 

39

53

 

COMMERCIAL OPERATIONS

 

PURCHASES

Import Percentage: 93%

Imports from: UE-RESTO DEL MUNDO

National Distribution: 7%

SALES

Export Percentage: 65%

National Distribution: 35%

 

SUPPLIERS

BUSINESS NAME

INTERNATIONAL

EXQUIM SA

NO

FERRER ALIMENTACION SA

NO

ZOSTER,S.A

NO

GRUPO FERRER INTERNACIONAL SA

NO

FERRER INTERNACIONAL SA

NO

LABORATORIOS ROBERT SA

NO

LABORATORIOS NOVAG SA

NO

FERRER PHARMA INTERNATIONAL SA

NO

There are 8 Suppliers

 

CLIENTS

BUSINESS NAME

INTERNATIONAL

FERRER AZEVEDOS SA

NO

FERRER ANDROMACO SA

NO

TROMMSDORFF GMBH AND CO

YES

FERRER ALIMENTACION SA

NO

FERRER INTERNACIONAL SA

NO

PHARMA INTERNACIONAL,S.A

NO

GRUPO FERRER INTERNACIONAL,S.A

NO

FERRER PHARMA INTERNACIONAL SA

NO

ZOSTER SA

NO

LABORATORIOS ROBERT SA

NO

There are 13 Clients

 

  

Sales breakdown

          El 98% de su cifra de negocio corresponde a principios activos farmacéuticos y el resto a prestación de servicios y residuos.

 

Banks

 

ENTITY

BRANCH

ADDRESS

TOWN OR CITY

PROVINCE

BANCO BILBAO VIZCAYA ARGENTARIA, S.A.

 

 

BARCELONA

 

BANCO ESPAÑOL DE CREDITO, S.A.

 

 

BARCELONA

 

BANCO POPULAR ESPAÑOL, S.A.

 

 

BARCELONA

 

CAIXA D’ESTALVIS DE CATALUNYA,TARRAGONA I MANRESA

 

 

BARCELONA

 

CAJA DE AHORROS Y M.P. DE MADRID

 

 

BARCELONA

 

There are 7 bank entities registered

  

Brands

Brand name: INTERQUIM (Valid)

Type: DENOMINATIVE    Scope: NATIONAL    Date: 19/11/2002

Brand name: PHAMEUROPE (Valid)

Type: DENOMINATIVE    Scope: NATIONAL    Date: 29/04/1994

Brand name: PHARMAEUROPE (Valid)

Type: DENOMINATIVE    Scope: NATIONAL    Date: 01/01/1900

There are 5 brands, signs and commercial names

 

LEGAL STRUCTURE

 

Constitution Data

Register Date: 13/11/1978

 

Current structure data

Legal form: Joint-stock Company

Social Capital: 833.202,00 €

Paid-up capital: 833.202,00 €

 

Legal Aspects

Obligation to fill in Financial Statements: YES

Chamber census: YES (2009)

 

 

B.O.R.M.E.

(OFFICIAL COMPANIES REGISTRY GAZETTE)

 

Summary

·         Acts on activity: 1 (Last: 23/04/1996)

·         Acts on administrators: 73 (Last: 17/09/2010, first: 10/08/1990)

·         Acts on capital: 2 (Last: 18/10/1996, first: 09/03/1992)

·         Acts on creation: 0

·         Acts on filed accounts: 19 (Last: 21/09/2010, first: 28/12/1990)

·         Acts on identification: 0

·         Acts on Information: 1 (Last: 05/02/1993)

·         Acts on proceedings: 5 (Last: 22/11/2010, first: 17/07/1996)

 

Latest acts in B.O.R.M.E.

Most relevant acts of the last twelve months

ACT

DATE

NOTICE NUM.

TRADE REGISTER

Company’s mergers and takeovers

22/11/2010

34375

 

Takeover merger project filing

05/11/2010

993861

Barcelona

Takeover merger project filing

04/11/2010

986599

Murcia

Other acts

ACT

DATE

NOTICE NUM.

TRADE REGISTER

Appointments

17/09/2010

354153

Barcelona

Resignations

26/04/2010

165481

Barcelona

Appointments

06/04/2010

137129

Barcelona

Resignations

24/02/2010

78528

Barcelona

Appointments

24/12/2009

534933

Barcelona

Latest filed accounts

ACT

DATE

NOTICE NUM.

TRADE REGISTER

Annual Filed Accounts (2009)

21/09/2010

608690

Barcelona

Annual Filed Accounts (2008)

22/12/2009

1044725

Barcelona

Annual Filed Accounts (2007)

28/11/2008

1152569

Barcelona

 

 

PRESS ARTICLES

 

Press summary by type of information (last five years)

Legal notices: 1 (Last: 18/11/2010)

Structural Data: 0

Informative data: 0

Financial Information: 0

Negative information: 0

Business lines: 0

Historical press releases: 1 (Last: 02/07/1996)

 

Latest press article published

 18/11/2010 CINCO DIAS (Page 6) LEGAL ANNOUNCEMENTS

El accionista único de INTERQUIM SA (Sdad. Absorbente), el socio único de CHEMICAL LINK GENERICS SL, e IPROA SA, el accionista único de EXIM SA y la Junta Gral. de ZOSTER SA (Sdades. Absorbidas), aprobaron el 02/11/10 la fusión de dichas cías. 

 


FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.44.93

UK Pound

1

Rs.72.09

Euro

1

Rs.64.21

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.